Aclarion Net Tangible Assets from 2010 to 2026

ACON Stock  USD 2.73  0.02  0.73%   
Aclarion Net Tangible Assets yearly trend continues to be very stable with very little volatility. Net Tangible Assets are likely to grow to about 1.2 M this year. Net Tangible Assets is the total assets of Aclarion minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. View All Fundamentals
 
Net Tangible Assets  
First Reported
2010-12-31
Previous Quarter
1.2 M
Current Value
1.2 M
Quarterly Volatility
3.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Aclarion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aclarion's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 141.4 K or Interest Expense of 603 K, as well as many indicators such as Price To Sales Ratio of 2.93, Dividend Yield of 0.0 or PTB Ratio of 0.12. Aclarion financial statements analysis is a perfect complement when working with Aclarion Valuation or Volatility modules.
  
Build AI portfolio with Aclarion Stock
Check out the analysis of Aclarion Correlation against competitors.
To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.
Evaluating Aclarion's Net Tangible Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Aclarion's fundamental strength.

Latest Aclarion's Net Tangible Assets Growth Pattern

Below is the plot of the Net Tangible Assets of Aclarion over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Aclarion's Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aclarion's overall financial position and show how it may be relating to other accounts over time.
Net Tangible Assets10 Years Trend
Pretty Stable
   Net Tangible Assets   
       Timeline  

Aclarion Net Tangible Assets Regression Statistics

Arithmetic Mean(2,673,077)
Geometric Mean2,515,467
Coefficient Of Variation(141.85)
Mean Deviation2,212,620
Median(2,865,497)
Standard Deviation3,791,875
Sample Variance14.4T
Range15.2M
R-Value0.25
Mean Square Error14.4T
R-Squared0.06
Significance0.34
Slope184,026
Total Sum of Squares230.1T

Aclarion Net Tangible Assets History

20261.2 M
20251.2 M
2022M
2021-14 M
2020-8.3 M

About Aclarion Financial Statements

Aclarion investors utilize fundamental indicators, such as Net Tangible Assets, to predict how Aclarion Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Tangible Assets1.2 M1.2 M

Pair Trading with Aclarion

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aclarion position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclarion will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aclarion Stock

  0.67OTC Ocumetics Technology CorpPairCorr
  0.67AHC Austco HealthcarePairCorr

Moving against Aclarion Stock

  0.77VMD Viemed HealthcarePairCorr
  0.69QIPT Quipt Home Medical Earnings Call TodayPairCorr
  0.654DX 4DMEDICALPairCorr
  0.44AMS Advanced Medical SolPairCorr
  0.44TRLS Trellus Health plcPairCorr
The ability to find closely correlated positions to Aclarion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aclarion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aclarion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aclarion to buy it.
The correlation of Aclarion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aclarion moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aclarion moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aclarion can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Aclarion is a strong investment it is important to analyze Aclarion's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aclarion's future performance. For an informed investment choice regarding Aclarion Stock, refer to the following important reports:
Check out the analysis of Aclarion Correlation against competitors.
To learn how to invest in Aclarion Stock, please use our How to Invest in Aclarion guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Will Health Care Equipment & Supplies sector continue expanding? Could Aclarion diversify its offerings? Factors like these will boost the valuation of Aclarion. If investors know Aclarion will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aclarion data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(12.12)
Revenue Per Share
0.108
Quarterly Revenue Growth
0.761
Return On Assets
(0.44)
Return On Equity
(0.88)
Investors evaluate Aclarion using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Aclarion's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Aclarion's market price to deviate significantly from intrinsic value.
Understanding that Aclarion's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aclarion represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Aclarion's market price signifies the transaction level at which participants voluntarily complete trades.